Coronavirus, Drugs, Health Policy

Lifesaving COVID Medications Can Be Hard to Come By

Early in the pandemic, states competed for the limited supply of ventilators, personal protective equipment and tests in a chaotic free-for-all. To avoid a repeat, the federal government is buying millions of doses of the COVID-19 therapeutic medications and allocating those to states, which in turn distribute them to pharmacies or hospitals. In many places, what is arriving is far less than the need.

flu cold patient bed influenza sick
Drugs, Influenza/Flu

Why taking fever-reducing meds and drinking fluids may not be the best way to treat flu and fever

As flu season progresses, so does the chorus of advice, professional and otherwise, to drink plenty of fluids and take fever-reducing medications, like acetaminophen, ibuprofen or aspirin. These recommendations, well-intentioned and firmly entrenched, offer comfort to those sidelined with fever, flu or vaccine side effects. But you may be surprised to learn the science supporting these recommendations is speculative at best, harmful at worst and comes with caveats.

Coronavirus, Laboratory Medicine

What Patients Can Learn With Confidence From One Negative Rapid Test (Hint: Very Little)

There are just so many variables. Testing may come either too soon, before enough virus is present to detect, or too late, after a person has already spread the virus to others. And most rapid tests, even according to their instructions, are meant to be used in pairs — generally a day or two apart — for increased accuracy. Despite that, a few brands are sold one to a box and, with the tests sometimes expensive and in short supply, families are often relying on a single screening.

Supreme Court building
Coronavirus, Health Policy, Politics, Vaccines

Justices Block Broad Worker Vaccine Requirement, Allow Health Worker Mandate to Proceed

The OSHA rules are opposed by many business groups, led by the small business advocacy organization the National Federation of Independent Business. It argued that allowing the rules to take effect would leave businesses “irreparably harmed,” both by the costs of compliance and the possibility that workers would quit rather than accept the vaccine.